S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)

Welltower (WELL) Stock Forecast, Price & News

$82.83
-0.91 (-1.09%)
(As of 09/22/2023 ET)
Compare
Today's Range
$82.70
$84.37
50-Day Range
$78.60
$85.47
52-Week Range
$56.50
$86.72
Volume
2.52 million shs
Average Volume
2.24 million shs
Market Capitalization
$42.97 billion
P/E Ratio
360.15
Dividend Yield
2.95%
Price Target
$85.67

Welltower MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.91 Rating Score
Upside/​Downside
3.4% Upside
$85.67 Price Target
Short Interest
Healthy
2.40% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.13
Upright™ Environmental Score
News Sentiment
0.92mentions of Welltower in the last 14 days
Based on 20 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.42%
From $3.55 to $3.92 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Finance Sector

490th out of 809 stocks

Real Estate Investment Trusts Industry

104th out of 172 stocks


WELL stock logo

About Welltower (NYSE:WELL) Stock

Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.

WELL Price History

WELL Stock News Headlines

Welltower (NYSE:WELL) PT Raised to $95.00
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Welltower (NYSE:WELL) Downgraded to Sell at StockNews.com
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Comparing Welltower (NYSE:WELL) & Douglas Emmett (NYSE:DEI)
Here's Why Welltower (WELL) is a Great Momentum Stock to Buy
Mizuho Increases Welltower (NYSE:WELL) Price Target to $90.00
Welltower (WELL) Sees Robust Operating Trend, Raises View
Welltower (WELL) Receives a Buy from Scotiabank
Welltower (NYSE:WELL) Upgraded by StockNews.com to Hold
Welltower Boosts FY23 NFFO Guidance
7 Analysts Have This to Say About Welltower
See More Headlines
Receive WELL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Welltower and its competitors with MarketBeat's FREE daily newsletter.

WELL Company Calendar

Last Earnings
5/02/2023
Ex-Dividend for 8/23 Dividend
8/14/2023
Dividend Payable
8/23/2023
Today
9/22/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
CUSIP
42217K10
Employees
514
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$85.67
High Stock Price Forecast
$95.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+3.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.91
Research Coverage
11 Analysts

Profitability

Net Income
$141.21 million
Pretax Margin
3.27%

Debt

Sales & Book Value

Annual Sales
$5.86 billion
Cash Flow
$3.04 per share
Book Value
$44.46 per share

Miscellaneous

Free Float
518,314,000
Market Cap
$42.97 billion
Optionable
Optionable
Beta
1.05

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Shankh S. MitraMr. Shankh S. Mitra (Age 42)
    CEO & Director
    Comp: $3.81M
  • Mr. Timothy G. McHugh (Age 38)
    Exec. VP & CFO
    Comp: $1.86M
  • Mr. John F. Burkart (Age 59)
    Exec. VP & COO
    Comp: $1.64M
  • Mr. Matthew Grant McQueen J.D. (Age 50)
    Exec. VP, Gen. Counsel & Corp. Sec.
    Comp: $1.25M
  • Ms. Ayesha M. Menon (Age 41)
    Exec. VP of Wellness Housing & Devel.
    Comp: $1.21M
  • Mr. Nikhil Chaudhri
    Exec. VP & Chief Investment Officer
  • Mr. Joshua T. Fieweger (Age 42)
    Sr. VP & Chief Accounting Officer
  • Mr. Krishna Soma
    Sr. VP of Corp. Fin.
  • Jack Rahner
    Sr. VP of Technology
  • Mr. John Olympitis
    Sr. VP & Head of Corp. Devel.













WELL Stock - Frequently Asked Questions

Should I buy or sell Welltower stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Welltower in the last twelve months. There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" WELL shares.
View WELL analyst ratings
or view top-rated stocks.

What is Welltower's stock price forecast for 2023?

11 analysts have issued 1-year price objectives for Welltower's shares. Their WELL share price forecasts range from $70.00 to $95.00. On average, they expect the company's share price to reach $85.67 in the next twelve months. This suggests a possible upside of 2.9% from the stock's current price.
View analysts price targets for WELL
or view top-rated stocks among Wall Street analysts.

How have WELL shares performed in 2023?

Welltower's stock was trading at $65.55 at the beginning of the year. Since then, WELL shares have increased by 27.0% and is now trading at $83.25.
View the best growth stocks for 2023 here
.

When is Welltower's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our WELL earnings forecast
.

How were Welltower's earnings last quarter?

Welltower Inc. (NYSE:WELL) issued its earnings results on Tuesday, May, 2nd. The real estate investment trust reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.82 by $0.77. The real estate investment trust had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.57 billion. Welltower had a net margin of 1.90% and a trailing twelve-month return on equity of 0.56%. The company's quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.82 EPS.
Read the conference call transcript
.

How often does Welltower pay dividends? What is the dividend yield for Welltower?

Welltower declared a quarterly dividend on Monday, July 31st. Stockholders of record on Tuesday, August 15th will be paid a dividend of $0.61 per share on Wednesday, August 23rd. This represents a $2.44 annualized dividend and a dividend yield of 2.93%. The ex-dividend date of this dividend is Monday, August 14th.
Read our dividend analysis for WELL
.

Is Welltower a good dividend stock?

Welltower (NYSE:WELL) pays an annual dividend of $2.44 per share and currently has a dividend yield of 2.86%. The dividend payout ratio is 1,060.92%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, WELL will have a dividend payout ratio of 62.24% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WELL.

What guidance has Welltower issued on next quarter's earnings?

Welltower updated its FY23 earnings guidance on Monday, September, 11th. The company provided earnings per share guidance of $3.51-3.60 for the period, compared to the consensus earnings per share estimate of $3.55.

What is Shankh Mitra's approval rating as Welltower's CEO?

1 employees have rated Welltower Chief Executive Officer Shankh Mitra on Glassdoor.com. Shankh Mitra has an approval rating of 100% among the company's employees. This puts Shankh Mitra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Welltower own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Welltower investors own include AT&T (T), Verizon Communications (VZ), Ventas (VTR), Johnson & Johnson (JNJ), Pfizer (PFE), Intel (INTC), Cisco Systems (CSCO), AbbVie (ABBV), Exxon Mobil (XOM) and Chevron (CVX).

What is Welltower's stock symbol?

Welltower trades on the New York Stock Exchange (NYSE) under the ticker symbol "WELL."

Who are Welltower's major shareholders?

Welltower's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.30%), Cohen & Steers Inc. (7.33%), State Street Corp (6.21%), Capital International Investors (4.12%), Geode Capital Management LLC (2.22%) and Principal Financial Group Inc. (1.99%).
View institutional ownership trends
.

How do I buy shares of Welltower?

Shares of WELL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Welltower's stock price today?

One share of WELL stock can currently be purchased for approximately $83.25.

How much money does Welltower make?

Welltower (NYSE:WELL) has a market capitalization of $43.18 billion and generates $5.86 billion in revenue each year. The real estate investment trust earns $141.21 million in net income (profit) each year or $0.23 on an earnings per share basis.

How many employees does Welltower have?

The company employs 514 workers across the globe.

How can I contact Welltower?

Welltower's mailing address is 4500 DORR STREET, TOLEDO OH, 43615. The official website for the company is www.welltower.com. The real estate investment trust can be reached via phone at (419) 247-2800, via email at sestes@welltower.com, or via fax at 419-247-2826.

This page (NYSE:WELL) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -